;

Articles Not Curated-Drug
Total hit(s): 397
S.No.
1
33538646
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection
Emerg Microbes Infect
2021 Dec
5.84
1
2
33691601
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract
Emerg Microbes Infect
2021 Dec
5.84
3
33823185
Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
Eur J Pharmacol
2021 Jun 15
3.24
4
33775840
Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
Bioorg Med Chem Lett
2021 Jun 1
5
32621739
Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID)
Clin Infect Dis
2021 May 4
7.71
6
33871567
SARS-CoV-2 spike therapeutic antibodies in the age of variants
J Exp Med
2021 May 3
10.35
7
33957246
Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library
Bioorg Med Chem Lett
2021 May 3
8
33813272
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
Biochem Biophys Res Commun
2021 May 28
2.73
9
33934306
In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes
Environ Sci Pollut Res Int
2021 May 2
~
10
33716308
Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies
Chem Phys Lett
2021 May 16
1.92
11
33970798
A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers
J Biomol Struct Dyn
2021 May 10
3.22
12
33721736
Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
Comput Biol Med
2021 May
2.93
13
33753421
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Gut
2021 May
15.78
14
33847768
[Antibody therapy in patients with COVID-19]
Internist (Berl)
2021 May
15
33785883
Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD
Nat Rev Gastroenterol Hepatol
2021 May
13.15
16
33713730
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors
Antiviral Res
2021 May
4.12
17
33825689
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
JMIR Public Health Surveill
2021 Apr 7
Cant find
18
33825201
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
Br J Pharmacol
2021 Apr 6
6.48
19
33917313
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
Pharmaceuticals (Basel)
2021 Apr 6
20
33932547
Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro
Microb Pathog
2021 Apr 28
2.64
21
33935562
Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
Saudi J Biol Sci
2021 Apr 28
22
33910954
Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity
J Virol
2021 Apr 28
4.16
23
33907209
A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials
Sci Rep
2021 Apr 27
4.12
24
33784094
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening
J Chem Inf Model
2021 Apr 26
4.04
25
33896392
Combined use of the hepatitis C drugs and amentoflavone could interfere with binding of the spike glycoprotein of SARS-CoV-2 to ACE2: the results of a molecular simulation study
J Biomol Struct Dyn
2021 Apr 26
3.22